U.S. stock markets have been witnessing an impressive rally since the beginning of 2023 barring some minor hurdles. Wall ...

Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab Injection (PD-1/CTLA-4 ...

The Biggest Shopping Weekend of the Year Black Friday and Cyber Monday are just around the corner, marking the year's most ...

The long sold-out Stalker 2: Heart of Chornobyl $80 Limited Edition is back in stock at Amazon. The $180 Collector's Edition ...

Western action-oriented philosophy pressures us to think that something must be done, something must be changed: stocks ...

The popular side dish is a staple on Thanksgiving, but two of its ingredients — BHA and BHT — are banned in the EU and other ...

While sharemarket floats can access deep capital for growing businesses, it’s essential to explore all available options to ...

Adventure travel operator Intrepid Travel has swung from fighting for survival to posting its strongest sales on record ...

People with HIV who need a kidney or liver transplant will be able to receive an organ from a donor with HIV under a new rule ...

Lucid Group (NASDAQ: LCID) is making waves in the luxury electric vehicle (EV) market with an impressive driving range that ...

The pan-European STOXX 600 was down 0.6% as of 0940 GMT and set to snap a three-day winning streak, with concerns over tariffs re-stoking global inflation and weighing on monetary-policy easing also ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...